Expression of p16, cyclin D1, CDK4 and retinoblastoma protein in acral lentiginous melanoma / Expressão da proteína p16, ciclina D1, CDK4 e proteína do retinoblastoma no melanoma acral lentiginoso

AUTOR(ES)

Ricardo Hsieh

DATA DE PUBLICAÇÃO

2008

RESUMO

INTRODUCTION: Acral lentiginous melanoma (ALM) has an expressive frequency between melanoma cases in our country, and it differs from the others clinical pathological types of cutaneous melanoma, because it does not have sun exposure as a predisposing factor. There are few publications in the literature addressing the expression of tumor suppressor pathway proteins in ALM. For these reasons we proposed to carry out a retrospective study aiming at a better understanding of p16 INK4a /cyclin D1/CDK4/pRb pathway involvement in ALM lesions. METHODS: Expression of p16, cyclin D1, CDK4 and pRB in 32 ALM lesions was displayed by immunohistochemistry. We compared the frequency of the expression of these markers in thin (thickness up to 1.0 mm) and thick lesions (thickness above 1.0 mm), as well as in accordance with the presence or absence of ulceration. RESULTS: 76% of the tumors were positive to p16 and 81% of the cases were positive to CDK4. There was no significant difference between the frequency of the expression of each marker when comparing in accordance with the thickness (thin and thick lesions) and the presence of ulceration. CONCLUSIONS: The expression of cyclin D1 and CDK4 in acral lentiginous melanoma may be considered aberrant and as reflex of a probable alteration in the p16/cyclin D1/CDK4/pRb tumor suppressor pathway. p16 and pRb tumor expression displayed by immunohistochemistry may not reflect probable alterations of the tumor suppressor pathway studied. The expression of these proteins, per se, may not be considered as prognostic factor in acral lentiginous melanoma

ASSUNTO(S)

quinase genes p16 ciclina d1 imunoistoquímica melanoma immunohistochemistry cyclin-dependent kinase 4 proteína do retinoblastoma genes p16 retinoblastoma protein cyclin d1 dependente de ciclina melanoma

Documentos Relacionados

• Prognostic impact of p16, cyclin D1, CDK4, pRb, p53 and p21 expression in head, neck and trunk melanomas
• "Expressão das proteínas ciclina D1, c-jun e do retinoblastoma e pesquisa do HPV em carcinomas epidermóides bucais"
• Study of expression of proteins Metalotioneína, NFkB, Ciclina D1 and Cdk4 in cell lines derived from human squamous cell carcinoma
• Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.
• Intestinal cell cycle regulations. Interactions of cyclin D1, Cdk4, and p21Cip1.